Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 36 (RPS2P36) is a **processed pseudogene** derived from the ribosomal protein S2 gene (RPS2)[5]. Pseudogenes such as RPS2P36 are non-functional remnants of protein-coding genes generated through retrotransposition or duplication events. While the parent RPS2 gene encodes a component of the small 40S ribosomal subunit and plays a role in protein synthesis[2][3][6], RPS2P36 itself does not encode a functional protein, has no known biological activity, and is dispersed in the genome among many other ribosomal pseudogenes as part of normal genomic architecture[5]. There is no evidence for a role of RPS2P36 in human disease, drug interactions, or therapeutic targeting. In summary, RPS2P36 is a **genomic pseudogene**, not a functional biological target. It does not fulfill criteria for molecular classification, function, or drug targeting—queries regarding its role as a receptor, enzyme, or disease gene are incorrect in the context of current scientific understanding[5][2][3][6].
None (Pseudogenes do not have mechanisms of action in drug pharmacology)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 36 (RPS2P36).